The authors have recently provided evidence implicating the cytochrome P-450 system in the generation of contractile tension of the ductus arteriosus. To confirm this possibility, carbon monoxide (CO/Oj ratio, 0.27) and cytochrome P-450 inhibitors [4-phenylimidazole; i4-isocyario,i5-(meth-oxymethyIeneoxy)-5Z,8Z,HZ-eicosatrienoic acid; 9-hydroxyellipticine; a-naphthoflavone) were tested on the isolated ductus arteriosus from mature fetal lambs equilibrated at low (4-26 mm Hg) or high (229-694 mm Hg) O, partial pressure (PoJ. Carbon monoxide completely relaxed intact vessel wall preparations and preparations consisting of only the muscle. Carbon monoxide relaxation was reversed by illumination with monochromatic light and the peak for the photoactivated contraction occurred at 450 nm. 4-PhehylimidazoIe (100 and 1,000 p.M) was also a relaxant agent, and its action was manifest at both low and high Po 3 . Unlike 4-phenylimidazole, the isonitrile compound (5 p.M) and 9-hydroxyellipticine (10 and 100 (xM) were relaxant only at low Po, and were also less potent. At the same Po 2 , a-naphthoflavone (10 \xM) barely reduced ductal tension. Treatment of the ductus with either a combination of superoxide dismutase (60 or 150 U/ml) and catalase (40 or 1,000 U/ml) or mannitol alone (80 mM) failed to alter the steady-state tone at low Po 2 and the contractile response to O 2 . Arachidonic acid was tested on tissues pretreated with the dual cyclooxygenase and lipoxygenase inhibitor, BW755C (10 (JLM), and produced a weak relaxation at a concentration of 1 JJLM or higher. 5,6-Epoxytrienoic acid relaxed the untreated tissue, and its action was abolished by indomethacin (2.8 (iM). Other arachidonic acid epoxides produced either a marginal relaxation (14,15-epoxytrienoic acid) or had no effect at all (8,9-and 11,12-epoxytrienoic acids). These findings confirm the existence in the lamb ductus arteriosus of a cytochrome P-450-)inked mechanism sustaining muscle tone and possibly the contraction of O 2 . The actual constrictor could not be identified with a monooxygenasederived product of arachidonic acid and remains to be characterized. (Circulation Research
C losure of the ductus arteriosus occurs shortly after birth and is known to be triggered by the natural rise in blood oxygen tension. Through the years, there has been considerable speculation on whether the action of oxygen is exerted directly on muscle cells or through an intermediary agent with constrictor properties. Several vasoactive compounds, including prostanoids and autonomic transmitters, have been considered for the latter role; however, none of them proved to be suitable. 1 The alternative hypothesis of a direct effect of oxygen has been formulated by Fay 2 on the basis of data implicating the terminal oxidase of the cytochrome chain in the oxygen-contraction coupling. Although appealing, the possibility of oxidative energy metabolism conditioning the oxygen response has been challenged. 3 We have previously proposed that a cytochrome P-450-mediated reaction sustains the contractile state of the ductus arteriosus and possibly its response to oxygen. 4 A tentative scheme was also suggested implicating arachidonic acid as a substrate for this reaction. In the present investigation, our proposal has been verified by examining the effectiveness of monochromatic light of various wavelengths to reverse the carbon monoxide-induced ductal relaxation and by testing cytochrome P-450 inhibitors of diverse chemical structure. In addition, the feasibility of arachidonic acid generating a ductus constrictor was tested by studying the response to the fatty acid and its epoxide derivatives. An isolated preparation of Iamb ductus arteriosus 5 was used in both lines of experimentation.
Materials and Methods
Experiments were performed on. ductuses from near-term (138-147 days gestation; term, 148 days) fetal lambs of Columbia-Rambouillet or Dorset-Rambouillet crossbreed.
General Procedure
The procedure for cesarean delivery of lambs arid isolation of the ductus arteriosus followed a published protocol: 5 The ductus was freed of loose connective tissue and cut circularly to yield two strips 1-2 mm wide and about 10 mm long. Only one strip was prepared for experiments in which the bath fluid was equilibrated with a gas mixture containing carbon monoxide (see below). Ductal strips were used intact, except for a few instances in which preparations were either endothelium-free or comprised the muscle layer alone. While the endothelium was removed by rubbing filter paper (No. 41, Whatman, Clifton, New Jersey) over the intimal surface, the tunica media was separated from intima and adventitia following the natural cleavage planes. 6 Ductal preparations, whole or stripped, were mounted in individual 10-ml organ baths between a stationary glass rod and an isometric tension transducer (FT .03C, Grass, Quincy, Massachusetts) coupled to a Grass polygraph. Baths were made of glass and had a water jacket to keep the temperature constant at 37° C. The initial load was applied quickly (intact or endothelium-free ductus, 1.5-1.8 g) or gradually (ductal muscle alone, 0.8-1.5 g) and preparations were stretched by about 50% of the original length to obtain optimal tension output. 7 Perfusion rate of the fluid through the baths was approximately 2 ml/min. Tissues were equilibrated in Krebs solution gassed with 5% CO 2 in N 2 , and the same gas mixture or mixtures of N 2 and O 2 containing 5% CO 2 were employed in the actual experiments. Both the fluid reservoir and organ bath were continuously bubbled with the required gas mixture. The O 2 partial pressure (Po 2 ) of the medium was measured with an Instrumentation Laboratory gas analyzer (model 1301, Lexington, Massachusetts) and was 4-15, 19-26, 229-262, and 584-694 mm Hg when using, respectively, gas mixtures with 0%, 2.5%, 30%, and 95% O 2 . In those instances in which carbon monoxide was tested on the ductus, the flow of fluid was stopped and a CO-O 2 mixture (9.1% CO-33.2% O 2 -8.1% CO 2 in N 2 ) was delivered to the organ bath through a separate inlet. This mixture was bubbled alone since it gave values of Po 2 and pH close to those obtained with the reference mixture of 30% O 2 -5% CO 2 in N 2 . Pure carbon monoxide was used in a few experiments and was bubbled together with the mixture of 5% CO 2 in N 2 or Q 2 . Any gas mixture with a CO/O 2 ratio lower than 1 is unlikely to inhibit cytochrome oxidase. 8 Perfusion through the bath was restored intermittently in cases of extended carbon monoxide treatment. Precautions were taken to avoid any leakage of carbon monoxide into the ambient air. 4 Illumination was kept constant, except in experiments with carbon monoxide in which the room was darkened.
Photoactivation Spectrum
Reversibility of carbon monoxide relaxation was ascertained by exposing ductal strips to monochromatic light of various wavelengths. Preparations were illuminated with a 75-W xenon-arc lamp (model XBO 75W/2, Osram, Eindhoven, Holland) in an organ bath whose far side had been covered with aluminum foil. The lamp was fitted inside a water-cooled, highefficiency housing (model ALH215 Photochemical Research Associates, London, Ontario, Canada) and was energized with a 150-W regulated power supply (model M304, Photochemical Research Associates). Prior to reaching the tissue, the light beam was first passed through a monochromator (model B102/2, Photochemical Research Associates) and was then focused over an appropriately narrow band. The light output from the monochromator was measured with a laser power monitor (model 300 A/W, Ophir, Jerusalem), and its intensity was kept constant with a neutral density filter (level set at 33-48 mW) through the desired wavelength range (400-500 nm).
The activation spectrum for the photoactivated contraction was determined by varying the wavelengths in 10-to 30-nm steps and repeating the illumination sequence two or even three times. At any wavelength, illumination was continued until the contraction had reached a stable plateau, and the interval between successive illuminations was adjusted to allow reversal of the response. In most experiments, the illumination sequence was also carried out in the absence of carbon monoxide treatment to demonstrate any relaxing effect of monochromatic light on the contracted tissue. The temperature of the fluid inside the bath was measured in control tests and was unaffected by the light.
Solutions and Drugs
The Krebs solution had the following composition (mM): NaCl 118, KC1 4.7, CaCl 2 2.5, KH 2 PO 4 1, MgSO 4 0.9, dextrose 11.1, and NaHCO 3 25. Potassium-Krebs solution (20 mM) was prepared by substituting sodium chloride with an equimolar amount of potassium chloride. The pH of the solution was 7.4 after equilibration with gas mixtures containing 5% CO 2 .
The following compounds were used: (±)-5, 6-epoxy-8Z,llZ,14Z-eicosatrienoic acid (Upjohn, Kalamazoo, Michigan); (±)-8,9-epoxy-5Z,llZ,14Zeicosatrienoic acid; (±)-ll,12-epoxy-5Z,8Z,14Zeicosatrienoic acid (Upjohn); (±)-14,15-epoxy-5Z, 8Z,llZ-eicosatrienoic acid (Upjohn); (±)-5,6-dihydroxy-8,ll,14-eicosatrienoic acid, 8-lactone (Upjohn); (± )-5,6-dihydroxy-8,ll,14-eicosatrienoic acid (Upjohn); indomethacin (Sigma Chemical, St. Louis, Missouri); 4-phenylimidazole (Aldrich, Milwaukee, Wisconsin); a-naphthoflavone (Sigma); metyrapone (Sigma); 9-hydroxyellipticine (gift of Dr. P. Lesca, Toulouse, France); catalase (CAT) (from bovine liver, 10,000-25,000 U/mg protein; Sigma); superoxide dismutase (SOD) (from bovine erythrocytes, 3,000 U/mg protein; Sigma) D-mannitol (Sigma); and 3-amino-l-(m-(trifluoromethyl)-phenyl)-2-pyrazoline (compound BW755C; Wellcome Research Laboratories, Langley Court, Beckenham, England).
Arachidonic acid was obtained from Nu-Check (Elysian, Minnesota) and was purified by silicic acid column chromatography 5 prior to use. The inhibitor of arachidonate monooxygenase, 14-isocyano,15-(methoxymethyleneoxy)-5Z,8Z,HZ-eicosatrienoic acid, sodium salt (isonitrile compound), was synthesized according to a published procedure. 9 Purified arachidonic acid (2.4 mg) was dissolved in ethanol (0.1 ml) and was then reacted with a stoichiometric amount of Na 2 CO 3 (16 mM) to form the sodium salt. The solution containing the salt was diluted with Tris buffer (50 mM, pH 9) for tests on the ductus. Throughout this procedure, arachidonate was not exposed to light and was also protected from ambient air by purging the vessels with nitrogen. Epoxyeicosatrienoic acids were dissolved in argon-degassed ethanol (2-10 mg/ml) and stored at -70° C. On the day of the experiment, an aliquot of the ethanol solution was placed in an acetone/solid CO 2 bath and, immediately prior to use, was diluted with ice-cold Tris buffer (50 mM, pH 9). The same procedure was employed with the 8-lactone and the diol derived from 5,6-epoxyeicosatrienoic acid. Sodium arachidonate and eicosatrienoic acids were tested in sequential doses, using 10-fold increments in 0.1-ml volumes. The isonitrile compound was also dissolved in ethanol (1-9 mg/ml), and aliquots of the stock solution (stored at -70° C) were either added directly to the Krebs medium in the reservoir or diluted with Tris buffer (50 mM, pH 9) prior to injection into the organ bath. Indomethacin and 9-hydroxyellipticine were dissolved, respectively, in ethanol (10 mg/ml) and 0.2 M acetate buffer (pH 5.0) (2.6 mg/ml) prior to preparation Of the final solution in Krebs medium. All remaining compounds dissolved readily in the Krebs solution, except for a-naphthoflavone, which required gentle heating and sonication. All concentrations refer to the final molar concentration in the bath. Doses of cytochrome P-450 inhibitors (4-phenylimidazole, isonitrile, 9-hydroxyellipticine, and a-naphthoflavone) and scavengers of oxygen-derived free radicals (SOD, CAT, and mannitol) were selected on the basis of data in the literature.
Light and Electron Microscopy
Ductal preparations whose intimal surface had been rubbed or had both intimal and adventitial layers removed were subjected, respectively, to scanning electron microscopy and light microscopy to verify the success of the stripping procedure. In either case, specimens were gently stretched and pinned to a wax board prior to fixation in Universal fixative. 10 For routine histology, they were subsequently embedded in paraffin and serial transverse sections were stained with hematoxylin-eosin. For electron microscopy, they were dehydrated in acetone, critical-point dried using liquid CO 2 , coated with gold, and then examined in a scanning microscope (model JSM-35, JEOL). While light microscopy confirmed that the appropriate vessel layers had been removed, scanning electron microscopic examination of the intimal side revealed a cell-free, fibrillar surface denoting exposed subendothelial connective tissue.
Analysis of Data
Contractile tension, which varied with the preparation and the experimental condition (see "Results"), is given after correction for the applied tension. The data are expressed as the mean ± SEM and were statistically analyzed using Student's / test for paired and unpaired observations. Multiple comparisons were made with an analysis of variance followed, when appropriate, by the Tukey standardization range test. Differences are considered significant with p< 0.05.
Results

Carbon Monoxide Relaxation and Its Reversal by Light
Intact ductal strips developed a variable degree of tension during equilibration in a low-Po 2 medium (4-15 mm Hg, 3.1±0.1 g; 19-26 mm Hg,~2.8±0.1 g) and contracted further upon exposure to oxygen (229-262 mm Hg, 4.3 ± 0 . 3 g; 584-694 mm Hg, 5.8±0.3 g). A similar behavior was observed with endothelium-free strips and with strips comprising the muscle layer alone, though values of tension were on the average 63% lower with the latter preparation. All preparations were contracted by the cyclooxygenase inhibitor indomethacin (2.8 |xM), and in keeping with previous results, 6 the response was relatively greater at a low Po 2 . Table 1 reports the steady-state tension of indomethacin-treated tissues prior to testing carbon monoxide.
Carbon monoxide completely or nearly completely reversed the contractile tension of both the intact ductus and muscle bundles ( Table 1) . With either preparation, relaxation began after a short delay (0.5-5.5 minutes), progressed rapidly (4-16 minutes) to a peak, and persisted for as long as the bathing fluid was gassed with carbon monoxide. After discontinuing carbon monoxide, preparations started to contract and in 16 to 52 minutes attained the original level of tone. Carbon monoxide-induced relaxation of muscle bundles subsided in part (54 ± 8%) during treatment with 20 mM K, which is consistent with early findings in the intact ductus. 4 Illumination of the intact ductus with monochromatic light over the range of 400-500 nm reversed the carbon monoxide relaxation. As shown in Figure 1 , the magnitude of the photoactivated contraction varied with the wavelength, the maximum occurring at 450 nm. The same figure also shows that monochromatic light exerted a direct relaxing effect that, compared with the photoactivated contraction, was smaller and was better developed at lower wavelengths. Lightinduced contraction and relaxation differed not only in their activation spectrum but also in their time course. Both responses had an instantaneous onset; however, relaxation progressed rapidly (1-3 minutes) to a peak Values are mean ± SEM for the number of preparations given in brackets. Preparations were allowed to equilibrate at 229-262 mm Hg and were treated with indomethacin 2.8 fiM. Carbon monoxide was used as a gas mixture in which the CO/O 2 ratio was 0.27 (see "Materials and Methods"). In additional trials with muscle bundles, pure carbon monoxide was delivered to the bath together with 95% N 2 -5% CO 2 (four preparations) or 95% O 2 -5% CO 2 (four preparations) mixtures and steady-state tension decreased by, respectively, 115±7%(from 1.9±0.2g)and 109±3%(from2.4±0.3g). Here and in Table 2 , values of tension refer to the net active tension developed by the preparation (i.e., total tension minus applied tension). 7 ±0.2 g) . Values for the relaxation are normalized against the response observed at 450 nm (0.9 ±0.2 g). The normalization factor, 19%, stands to indicate that mean photorelaxation is 19% of mean photocontraction. Note that the two spectra were obtained in the same tissues (five preparations) and that the photorelaxation activation spectrum applies to maximal responses (see text). and then often abated despite continued illumination (partial or complete reversal in 6-22 minutes), while contraction developed gradually (5-21 minutes) to a stable plateau. This difference in pattern would predict that the relaxing effect of light is unlikely to interfere with the contractile effect. In fact, even after correcting the photocontraction spectrum for any concurrent photorelaxation, maximum contraction still occurred around 450 nm.
Effect of Cytochrome P-450 Inhibitors
Cytochrome P-450 inhibitors of diverse chemical structure relaxed ductus preparations preequil ibrated in a low-Po 2 medium containing indomethacin ( Table 2) . While 4-phenylimidazole exerted a dose-dependent effect, no such dependence was observed with 9hydroxyellipticine. Furthermore, 4-phenylimidazole was more potent than either the isonitrile or 9-hydroxyellipticine. The response to ot-naphthoflavone, on the other hand, was barely significant at the highest dose tested. In all cases, relaxation developed gradually (range, 20-100 minutes depending on compound and dose), and its time course was reminiscent of earlier findings with metyrapone. 4 In fact, preliminary tests in this series confirmed that 100 |iM metyrapone causes a 24% reversal in active tension (two preparations). With the exception of 4-phenylimidazole, none of the inhibitors modified the contractile response to oxygen ( Table 2) . 4-Phenylimidazole, like metyrapone, 4 significantly reduced this response. In separate experiments, isonitrile (5 jiM) was tested in the absence of indomethacin, and in keeping with the findings in Table 2 , it relaxed the hypoxic vessel (1.7 ± 0 . 4 versus 3.6±0.6 g ; p < 0 . 0 1 ; five preparations) while leaving the oxygen-contracted vessel unaffected (5.5 ± 0 . 5 versus 5.7±0.5 g; NS; four preparations). Unlike 4-phenylimidazole, imidazole 0.1-1 mM was a weak ductus constrictor, both in the absence and presence of indomethacin and regardless of the Po 2 of the medium (data not shown).
Action of Free Radical Scavengers
Oxygen-derived free radicals may be generated in a multiplicity of reactions, including cytochrome P-450-linked reactions." Their possible involvement in ductal function has been examined by treating the vessel with either a combination of SOD (60 U/ml) and CAT (40 U/ml) or with mannitol (80 mM) alone. None of the scavengers, however, altered the steady-state tone of the hypoxic ductus (7-12 mm Hg; 10 preparations). Furthermore, the contractile response to oxygen (654-680 mm Hg) had a similar magnitude before and after treatment, tension values being 6.5 ± 0.6 g (eight preparations) and 6.9 ± 0.5 g (SOD plus CAT; six preparations) or 6.1 ± 0 . 6 g (mannitol; four preparations), respectively. Two additional preparations were exposed to oxygen in the presence of higher concentrations of SOD (150 U/ml) and catalase (1,000 U/ml), and the ensuing contraction also did not differ from controls.
Effects of Arachidonic Acid and Its Epoxides
Previous work has shown that arachidonic acid relaxes the ductus in vitro 12 and in vivo. 13 Its action was reassessed here using tissues pretreated with the dual cyclooxygenase and lipoxygenase inhibitor, BW755C (10 fiM), to favor any existing monooxygenase-type reaction. The inhibitor by itself mimicked indomethacin (see above) in raising the steady-state tone of the hypoxic ductus (19-20 mm Hg) from a control value of 1.7 ± 0.3 to 3.8 ±0.4 g (p<0.01; six preparations). Arachidonic acid (0.01-10 (xM), however, remained a relaxing agent, its threshold concentration being around 1 \LM. At 10 \iM, the relaxation amounted to 2.1 ± 0 . 3 g (six preparations). A response of similar sign, but smaller amplitude (0.6 ± 0.1 g at 10 JJLM; six preparations), was observed at high Po 2 (660-678 mm Hg). 5,6-Epoxytrienoic acid also relaxed the ductus in a dose-dependent manner, and its action was abolished (2) 6.6 ±0.6 (6) Values (g) are mean±SEM for the number of preparations given in parentheses. Perfusion medium contained indomethacin 2.8 ftM. With the exception of experiments with isonitrile, tissues were transferred from low to high Poj in the presence of the inhibitor and, therefore, individual controls at high P02 are missing. Statistical analysis of differences between control and treatment groups included, in the order, an analysis of variance and a paired (low P02 data plus high Poj data for isonitrile) or unpaired (high P02 data) / test. Note that a-naphthoflavone induces type I spectral changes, while the remaining inhibitors, including metyrapone (not shown), produce type II changes. by indomethacin ( Figure 2 ). Over the same doserange, the 8-lactone and the diol derived from 5,6-epoxytrienoic acid were without effect (four preparations). Likewise, 8,9-and 11,12-epoxytrienoic acids (0.001-10 JJLM) were inactive (two and four preparations, respectively), whereas 14,15epoxytrienoic acid was a weak relaxant at the highest dose tested (maximum 0.4 g at 10 u-M; eight preparations). Additional experiments were performed with endothelium-free preparations to avoid any interference from relaxing agents formed in endothelial cells. 1415 However, responses of the denuded ductus to arachidonic acid (two preparations) and its 5,6-epoxide (four preparations) were identical to those of the intact ductus.
Discussion
The present investigation confirms the existence in the ductus arteriosus of a cytochrome P-450-1 inked mechanism sustaining the contractile tension of the vessel and possibly its response to oxygen. Our conclusion is based on the fol lowing findings: 1) carbon monoxide relaxes both intact vessel wall preparations and muscle bundles and, in exerting this effect, shows greater affinity for the target site than oxygen; 2) carbon monoxide relaxation is reversed by monochromatic light and, as expected from the photodissociation of a cytochrome P-450/carbon monoxide complex, the activation spectrum shows a peak at 450 nm; and 3) cytochrome P-450 inhibitors of diverse chemical structure mimic carbon monoxide in relaxing the ductus. Also consistent with our postulate are recent reports implicating the cytochrome P-450 system in other vascular responses; that is, the constriction of the ductus arteriosus to acetaminophen 16 and the dilatation of certain adult blood vessels to arachidonic acid. 15 -17 While documenting the presence of a functional cytochrome P-450 in the ductus, this study leaves unanswered the question of the identity of the reaction, or reactions, involved in the generation of the contractile tone. Our original scheme 4 tentatively identified the ductus constrictor with an eicosanoid and, accordingly, envisaged postnatal changes in the direction of arachidonic acid metabolism resulting in the intramural formation of a monooxygenase product. Such product would be formed at the expense of the cyclooxygenase product, conceivably prostaglandin 1^, that is held responsible for prenatal patency of the vessel. Indeed, in support of that scheme, it was found that carbon monoxide and high Po 2 have opposing effects on the rate of prostaglandin Ej synthesis in the isolated fetal ductus. 6 Though appealing, our hypothesis is not borne out by the present results. None of the epoxyacids tested lends itself to the role of effector of ductus closure. Likewise, arachidonic acid does not exert a contractile effect even under conditions favoring the monooxygenase pathway. If indicative of the normal situation, the latter finding would rule out an eicosanoid function altogether. In this context, it must be pointed out that the isonitrile compound is unlikely to be a selective inhibitor of arachidonate monooxygenase and may interfere with other monooxygenase reactions as well.
The present data are of little help in suggesting an alternative scheme for the operation of the cytochrome P-450 system in the ductus. Theoretically, this system could influence contractility nonspecificalry through the formation of free radicals. Ductal tissue is, in fact, endowed with a relatively low level of superoxide dismutase" and would therefore appear receptive to such action. However, this occurrence is unlikely since changes in ductal tension, including the oxygeninduced contraction, are reversible and, moreover, are not modified by treatment with free radical scavengers. More plausibly, cytochrome P-450 activity is exerted on a specific substrate whose identity remains to be ascertained. In this connection, it may not be a coincidence that contractile responses of the ductus are most effectively curtailed by cytochrome P-450 inhibitors producing type II spectral changes, while the monooxygenase-dependent vasodilation to arachidonic acid is sensitive to type I inhibitors. 15 Together, the latter findings imply the occurrence in vascular tissue of at least two, functionally distinct, species of cytochrome P-450. It remains to be explained why type II inhibitors are unevenly effective in reversing ductal tone. Several factors inherent to the identity of the target enzyme and the inhibitor itself may account for this finding. Metyrapone and 4-phenylimidazole exert an inhibitory effect on several cytochrome P-450 isozymes, and this broad spectrum of targets may comprise the enzyme functional in the ductus. By contrast, 9-hydroxyellipticine acts preferentially on the methylcholanthrene-induced cytochrome P-450," whose function is linked to the activation of carcinogens and toxic chemicals rather than physiological events. The lesser potency of the isonitrile, on the other hand, may derive from its fatty acid structure and the attendant possibility of extensive binding of the compound to unspecific sites through the tissue.
Two final points emerging from this work deserve a comment. Demonstration of the relaxant effect of 5,6-epoxytrienoic acid and its abolition by indomethacin raise the intriguing possibility of a monooxygenase product serving as a substrate for the cyclooxygenase. This reaction sequence has been documented elsewhere 20 and yields epoxyprostaglandins among the active end products. Such compounds, however, are unlikely formed in the ductus, at least in significant amounts, because cytochrome P-450 inhibitors are relaxant rather than contractile agents. Alternatively, added 5,6-epoxytrienoic acid may stimulate endogenous prostaglandin synthesis and this needs to be verified experimentally. Lastly, it is confirmed that light exerts a direct relaxing effect on ductal muscle, 21 which is consistent with data in other blood vessels. 22 While the mechanism of the relaxation remains unclear, this finding underlines the potential risk of increasing the incidence of patent ductus when subjecting premature infants to phototherapy. 23 
